Quote of the Day

"Managing drug costs is a highly complex area. There isn't a lot of market control, particularly over single-source drugs that come out, so the focus tends to be more on appropriateness and, in some instances, plans have used economic incentives — coinsurance, for example — to make it more difficult for people to get those drugs. I think what [Oregon's proposed "Cap the Copay" bill, H.B. 2951] is trying to do is eliminate that practice and force plans to make more value-based judgments in terms of formulary and other mechanisms that determine whether or not their members will have access to these medications."



— Mike Thompson, a senior analyst at PricewaterhouseCoopers LLP, told AIS's Health Plan Week.